WEBINAR 5.

It is our pleasure to invite you to watch the recording of our last webinar of series EXPERTS EXPLAIN.
Our speakers:
Nicolas Girard, the Institut du Thorax Curie Montsouris, Institut Curie, Paris, France
Arun Rajan, the National Cancer Institute, the National Institutes of Health (NCI/NIH), Bethesda, USA
Heather Wakelee, the Stanford University, Stanford, CA, USA
and Anne Tsao, the University of Texas M.D. Anderson Cancer Center, Houston, USA
are presenting: Clinical Trials for Thymic Epithelial Tumors.
Moderator: Dr. Malgorzata Szolkowska from the National Tuberculosis and Lung Diseases Research Institute, Warsaw, Poland
Clinical Trials presented in this webinar
NCT03134118: Nivolumab in Patients With Type B3 Thymoma and Thymic Carcinoma (NIVOTHYM)
NCT02724696: French National Observatory of Patients With Thymic Epithelial Tumor (RYTHMIC)
NCT04731610: Phase III, Opened, Randomized Study of Post-Operative Radiotherapy (PORT) versus Surveillance in Stage IIB/III of Masaoka Koga Thymoma after Complete Surgical Resection (RADIO-RYTHMIC)
Contact: nicolas.girard2@curie.fr
Institute Curie, Paris, France, 75005
Principal Investigator: Nicolas Girard
NCT04417660: Bintrafusp Alfa (M7824) in Subjects With Thymoma and Thymic Carcinoma
NCT03076554: Safety and Clinical Activity of Avelumab (MSB0010718C) in Thymoma and Thymic Carcinoma After Progression on Platinum-Based Chemotherapy
Contact: Shannon G. Swift, R.N., phone (+1) (240) 858-3157; email: shannon.swift@nih.gov
National Institutes of Health Clinical Center
Bethesda, Maryland, United States, 20892
Principal Investigator: Arun Rajan
NCT03583086: Phase I/II Trial of Nivolumab plus Vorolanib in patients with Thymic Carcinoma (and other thoracic cancers)
Contact: phone (+1) 800-811-8480, email: cip@vanderbilt.edu
Stanford Cancer Institute- California
Palo Alto, California, United States, 94304
Principal Investigator: Heather Wakelee
Winship Cancer Institute, Emory University- Georgia
Atlanta, Georgia, United States, 30322
Principal Investigator: Badi El Osta
University of Chicago Medical Center – Illinois
Chicago, Illinois, United States, 60637
Principal Investigator: Christine Bestvina
Baptist Clinical Research Institute – Tennessee
Memphis, Tennessee, United States, 38120
Contact: Baptist Cancer Center Clinical Research Office
Principal Investigator: Philip Lammers
Vanderbilt-Ingram Cancer Center – Tennessee * Coordinating Center
Nashville, Tennessee, United States, 37232
NCT03694002: Carboplatin and Paclitaxel With or Without Ramucirumab in Treating Patients With Locally Advanced, Recurrent, or Metastatic Thymic Cancer That Cannot Be Removed by Surgery
NCT03295227: Feasibility Trial of Pembrolizumab in Unresectable Thymoma and Thymic Carcinoma
Contact: Anne S. Tsao, phone (+1) 713-792-6363, email: astsao@mdanderson.org
University of Texas MD Anderson Cancer Center
Houston, Texas, United States, 77030
Principal Investigator: Anne S. Tsao
Thank you for attending our webinars!